Project Grant HT94252410916
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$891K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Denver, CO 80207, USA
Similar Awards
This federal Project Grant award, totaling $1,012,894.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate pain reprocessing therapy for veterans with chronic back pain. The 4-year award, with a start date of September 30, 2024, will compare the efficacy of this therapy and examine facilitators and barriers to implementation. The University of Colorado-Denver is the prime awardee, with sub-awards going to Texas...
The Defense Health Agency awarded a $2,206,031 project grant to Rush University Medical Center to fund the PREVENTING THE DEVELOPMENT OF CHRONIC PAIN: TREATING PTSD AT ACUTE PAIN ONSET program. The grant is part of the Military Medical Research and Development program (CFDA 12.420) and will support basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries. Specifically, the grant will fund...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $360,116.00 to the Regents of the University of Michigan to conduct research on "BRIEF PAIN REPROCESSING THERAPY: AN OPTIMIZED INTEGRATIVE EXPOSURE INTERVENTION FOR VETERANS WITH CHRONIC LOW BACK PAIN." The research project aims to develop and evaluate an innovative therapy to address chronic low back pain among veterans. The award has a...
This federal Project Grant award of $170,712.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research on the comparative effectiveness of exercise, cognitive behavioral therapy, and their combination for individuals with chronic musculoskeletal pain and poor sleep. The award, with a period of performance from September 30, 2024 to September 29, 2028, is funding research conducted by the University of Queensland in Australia. The...
This Project Grant award, valued at $399,729.00, was provided by the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a research project focused on the clinical effectiveness of nonopioid pain management approaches to improve outcomes among active-duty service members. The award was granted to the University of Illinois, which will conduct this research over a 2-year period from November 1,...
The Defense Health Agency has awarded a $1.632 million Project Grant to the Ocean State Research Institute, Inc., a non-profit research organization, to investigate the long-term outcomes of antipsychotic medication use in U.S. veterans with post-traumatic stress disorder (PTSD). This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. As...
The Defense Health Agency awarded a $2,528,000 Project Grant to the University of California, San Diego under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research titled "MULTIPLEXED IN VIVO EPIGENOME ENGINEERING FOR THERAPEUTIC TARGETING OF CHRONIC PAIN." The four-year project beginning June 1, 2022 will investigate medical solutions for chronic pain through innovative epigenome engineering research with the goal of transforming...
The federal Project Grant award of $5,954,349.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a randomized controlled trial to optimize heart rate variability in combat veterans and service members with persistent post-concussion symptoms. The award was made to Virginia Commonwealth University (VCU), which is collaborating with the Palo Alto Veterans Institute for Research (Pavir) and the Richmond Institute for...
This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $909,532.00 to The University of Texas Southwestern Medical Center to conduct research on validating a nonopioid analgesic pathway in human sensory ganglia and spinal cord. The award has a performance period from September 15, 2024 to September 14, 2025. The research aims to explore innovative, non-opioid based approaches to pain management, which is a...